Welcome to our dedicated page for NATIONAL HEALTHCARE SEC filings (Ticker: NHC), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Our SEC filing database is enhanced with expert analysis from Rhea-AI, providing insights into the potential impact of each filing on NATIONAL HEALTHCARE's stock performance. Each filing includes a concise AI-generated summary, sentiment and impact scores, and end-of-day stock performance data showing the actual market reaction. Navigate easily through different filing types including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, proxy statements (DEF 14A), and Form 4 insider trading disclosures.
Designed for fundamental investors and regulatory compliance professionals, our page simplifies access to critical SEC filings. By combining real-time EDGAR feed updates, Rhea-AI's analytical insights, and historical stock performance data, we provide comprehensive visibility into NATIONAL HEALTHCARE's regulatory disclosures and financial reporting.
National HealthCare Corp. (NHC) senior executive reports option exercise and share withholding. On 12/01/2025, the Senior VP & CIO exercised an option to purchase 3,734 shares of common stock at an exercise price of $63.96 per share, adding 3,734 acquired shares. On the same date, 2,385 shares were disposed of through share withholding at $137.29 per share to cover the exercise price and tax obligations. After these transactions, the executive beneficially owned 14,520.0547 shares of NHC common stock directly.
The report also shows remaining stock options, including options to purchase 7,467 shares at $53.94 per share exercisable from 03/08/2024 until 03/08/2028, 12,000 shares at $94.10 per share exercisable from 03/05/2025 until 03/05/2029, and 13,500 shares at $90.62 per share exercisable from 02/24/2026 until 02/24/2030.
National Healthcare Corp reported insider equity activity by its Senior Vice President of Patient Services. On 11/25/2025, the executive exercised options to purchase 4,000 shares of common stock at $94.10 per share (code M), increasing directly held stock. To cover the exercise price and tax withholding, the company withheld 3,140 shares at a value of $137.95 per share (code F). After these transactions, the executive directly owned 10,608.5455 shares of National Healthcare common stock.
The filing also shows outstanding stock options, including rights to acquire 3,734 shares at $53.94 per share exercisable until 03/08/2028, 8,000 derivative securities remaining from a grant at $94.10 per share expiring on 03/05/2029, and options for 13,500 shares at $90.62 per share exercisable starting 02/24/2026 and expiring on 02/24/2030. The options exercised and held were granted under the company’s 2020 Omnibus Equity Incentive Plan and are stated as exempt from Section 16(b) short-swing profit rules under Rule 16b-3(d).
National HealthCare Corp (NHC) filed a Form 4 reporting that director Emil E. Hassan sold 7,500 shares of common stock on 11/25/2025 in an open market transaction coded “S.” The shares were sold at a price of $138.5164 per share.
After this sale, Hassan directly owns 65,595 NHC common shares. He also holds several stock option awards, each covering 7,500 shares of common stock, with exercise prices ranging from $55.75 to $96.03 and expiration dates between 05/05/2026 and 05/07/2030.
National HealthCare Corp (NHC) CEO and director Stephen Flatt reported insider transactions on a Form 4. On 11/21/2025, he sold 1,000 shares of common stock at $130.33 per share, and after this trade he beneficially owned 59,130 shares. On 11/25/2025, he exercised 1,853 stock options at $53.94 per share, increasing his beneficial ownership to 60,983 shares.
The filing also lists his remaining stock options. He holds 6,147 options with a $53.94 exercise price expiring on 03/08/2028, 10,000 options with a $94.10 exercise price expiring on 03/05/2029, and 18,000 options with a $90.62 exercise price expiring on 02/28/2030. The exercised options were granted under the 2020 Omnibus Equity Incentive Plan and are described as exempt from Section 16(b) under Rule 16b-3(d).
National Healthcare Corp. (NHC) disclosed an initial beneficial ownership report for director Lisa Piercey. The filing states that, as of the reported event date of 11/06/2025, no securities of National Healthcare Corp. are beneficially owned. This is an administrative ownership disclosure required for insiders under securities regulations.
National HealthCare Corp. (NHC) President & COO Michael Ussery reported Form 4 transactions on 11/11/2025. He exercised 4,500 stock options at $53.94 and another 4,500 at $94.10. To cover the exercise price and withholding taxes, the company withheld 1,705 shares and 3,720 shares at $132.20.
After these transactions, he directly beneficially owned 161,523 shares. Remaining option holdings include 4,500 options at $53.94 expiring 03/08/2028, 9,000 options at $94.10 expiring 03/05/2029, and 15,000 options at $90.62 expiring 02/24/2030.
National Healthcare Corp. (NHC) reported insider activity by its Sr. VP of Operations on a Form 4. On 11/11/2025, the executive exercised 2,400 stock options with a $63.96 exercise price and another 4,800 stock options with a $53.94 exercise price, all granted under the 2020 Omnibus Equity Incentive Plan and exempt from Section 16(b) under Rule 16b-3(d.
To cover the exercise price and related tax withholding, the company withheld 1,655 shares and 3,091 shares, reported with transaction code “F” at a price of $132.20. After these transactions, the executive continued to hold common stock directly and also retained unexercised options, including 8,000 options at a $94.10 exercise price expiring on 03/05/2029 and 11,000 options at a $90.62 exercise price expiring on 02/24/2030.
National HealthCare Corp. (NHC) — Form 4 insider activity: Senior VP & General Counsel Josh McCreary exercised stock options and adjusted holdings on 11/11/2025. He acquired 4,000 shares of common stock via option exercise at $94.10 (Code M), then had 3,278 shares withheld to cover the exercise price and taxes (Code F) at $132.20. Following these transactions, he beneficially owned 10,438 shares directly.
Post‑transaction, derivative holdings include options with 8,000 remaining from a grant exercisable until 03/05/2029 at $94.10, plus other options of 4,000 at $53.94 (expiring 03/08/2028) and 13,500 at $90.62 (expiring 02/24/2030).
National HealthCare Corp. (NHC) reported an insider transaction by its SVP, CFO. On 11/11/2025, the officer exercised 4,000 stock options at $94.10 per share (Code M). To cover the exercise price and withholding taxes, 3,224 shares were withheld (Code F). Following these transactions, the officer directly owned 24,490 shares of common stock.
Remaining derivative holdings include options with exercise prices of $53.94 (8,000 shares outstanding), $94.10 (8,000 shares remaining from a 12,000 grant), and $90.62 (13,500 shares), with expirations between 2028 and 2030 as disclosed.
National Healthcare Corp. (NHC) CEO and director Stephen Flatt reported insider transactions on 11/11/2025. He exercised 3,000 options at $94.10 per share (code M) and the company withheld 2,480 shares to cover the exercise price and taxes (code F). Following these transactions, he beneficially owns 60,130 common shares.
Outstanding equity awards listed include options expiring on 03/08/2028 at $53.94 (8,000 shares), on 03/05/2029 at $94.10 (10,000 shares after the exercise), and on 02/28/2030 at $90.62 (18,000 shares).